Medisafe Launches Maestro Platform for Adherence
The new Medisafe Maestro platform seamlessly orchestrates medication adherence journeys with precision and speed, creating personalized patient support resources delivered through a digital drug companion. The platform supports patients across their unique treatment needs with tailored interventions and custom-picked resources delivered along with an integrated Care Connector which encourages real-time patient engagement.
Medisafe collaborates with partners to address individual patient challenges so they may navigate through any roadblocks to continue treatment. Maestro even increases the speed to market with functionalities such as Interactive Flow Mapping to design the inventory of supportive content, including rules and intervention deployment, and an archive of creative images and brand style; Central Command Center to manage the creation and collaboration of digital drug companions that digitize patient support programs; and Real-time Visibility that provides insights into patient journeys.
MJH Life Sciences Devises COVID-19 Coalition
The healthcare media company has brought together nationally recognized healthcare thought leaders in an advisory panel that will generate and share the most accurate, up-to-the-minute information on COVID-19’s impact on healthcare professionals and the patients they treat in the form of live webinars, white papers, infographics, and more. The ultimate goal of the COVID-19 Coalition is to equip providers with the resources they need to enhance patient outcomes as they navigate through the coronavirus pandemic.
“There is still much confusion among healthcare providers as they navigate patient care during the pandemic,” said Mike Hennessy Jr., President and CEO of MJH Life Sciences. “This is why we’ve assembled some of the brightest and most prominent thought leaders in healthcare to provide the latest and best guidance and direction.”
Some of the members of the expert-studded panel are Margaret Liu, MD, CEO, PAX Therapeutics; Angela Rasmussen, PhD, Associate Research Scientist, Center for Infection and Immunity, Columbia University Mailman School of Public Health; Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, Professor of Pediatrics, Feinberg School of Medicine, Northwestern University; and Amesh Adalja, MD, FIDSA, Senior Scholar, Johns Hopkins University Center for Health Security.
Fingerpaint Expands Data-Driven Offerings
Through the creation of the SHIFT Performance Center of Excellence, and the launch of its proprietary Actionable Intelligence Engine, Fingerpaint is expanding its capabilities in data-driven, performance marketing. The SHIFT Performance Center of Excellence, co-led by Nick Bartolomeo, Head of Media and Performance Marketing, and Bryan O’Malley, Head of Technology and Performance Innovation, broadens Fingerpaint’s data-fueled, omnichannel solutions that drive brand performance curated by 60 data scientists, developers, media experts, and digital strategists.
“SHIFT Performance has been powering successful brand strategies for nearly five years, driving measurable performance across multiple disease states and markets, including rare disease, prevalent conditions, and small and large pharma companies,” Bartolomeo said in a statement. “In some cases, we’ve seen a 300% lift of scripts above control. Layering in the new capabilities of our proprietary Actionable Intelligence Engine will give us deeper insights into audience behaviors to further optimize personalized brand journeys.”
The agency’s new Actionable Intelligence Engine takes machine learning and augments it with human expertise to deliver the next best content to every customer. This is the latest in a string of growth outcomes, coming shortly after Fingerpaint launched Photo 51, a consultancy focused solely on gene and cell therapies.
Amazon Trusts Sharecare to Power Alexa’s Health Info
Sharecare is a digital agency known for its comprehensive and data-driven virtual heath platform, making it the perfect resource for Amazon’s health and well-being information provided through the Alexa voice service. Sharecare will be integrating its library of more than 80,000 questions and answers on various topics, building upon the company’s commitment to democratize the availability of trusted health information and engage consumers in improving their well-being through innovations in voice technology.
“As the digital landscape of consumer health information grows increasingly crowded, determining the credibility of that information also can be challenging to navigate,” said Dawn Whaley, President of Sharecare. “For nearly a decade, Sharecare has partnered with more than 180 trusted health organizations as part of our mission to help people easily access the latest scientifically validated information to support their overall well-being. And with more than 19 million people in the U.S. actively using voice assistants to seek health information, being selected by Amazon’s Alexa to provide their customers with verified answers from Sharecare enables even more people to access what they need, when they need it, and through a frictionless experience.”
Sharecare is no stranger to empowering people to navigate their well-being through education. Their medically vetted content is created by in-house health journalists and digital producers in collaboration with leading healthcare providers, non-profit organizations, and academic institutions such as the Boston University School of Public Health which partnered with the agency to create the Community Well-Being Index (CWBI), a measure of well-being through the lens of social determinants of health that provides people with detailed rankings and deeper context on how their own health is impacted by where they work, live, and play.
MicroMass Launches Intersect Podcast
Intersect, the new podcast series from MicroMass Communications, tells stories of behavioral science in action. The series is about solving common pharma challenges and is designed for anyone in the business of healthcare who’s committed to providing treatments and experiences that improve patient health. Providing an in-depth view of how the agency works, each episode focuses on one person facing healthcare-related challenges, whom the MicroMass team talks with as they share their experiences. Then a team of specialists work at the intersection of behavioral science, creativity, and technology to build a more ideal, personalized experience for the patient. Using collaboration and advanced insights MicroMass demonstrates how their expertise can help pharma and life sciences companies meet their goals by leveraging how health behavior intersects with treatment.
“The heroes of these stories face chronic illness, communication breakdowns, social stigma, cultural barriers, and other obstacles to health and treatment,” states Johnny Knight, Intersect Producer and Senior Behavioral Copywriter at MicroMass. “Our team helps them overcome challenges and establish a renewed commitment to their health and well-being. It’s a must-listen for anyone who works in the business of healthcare and appreciates a good story.”
The Intersect podcast series is available on most syndication networks including iTunes, Google Podcasts, Spotify, Pandora, Stitcher, Pocket Casts, and TuneIn. New stories (with multiple episodes for each story) are scheduled to be released about every six weeks.
